Immune-Based Therapy in Triple-Negative Breast Cancer: From Molecular Biology to Clinical Practice

SIMPLE SUMMARY: Triple-negative breast cancer has been historically considered an orphan disease in terms of therapeutic options. To date, chemotherapy is still the mainstay of treatment both in the early and metastatic settings. Recent advances in the genomic and immunologic fields have revealed th...

Descripción completa

Detalles Bibliográficos
Autores principales: Carlino, Francesca, Diana, Anna, Piccolo, Antonio, Ventriglia, Anna, Bruno, Vincenzo, De Santo, Irene, Letizia, Ortensio, De Vita, Ferdinando, Daniele, Bruno, Ciardiello, Fortunato, Orditura, Michele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103968/
https://www.ncbi.nlm.nih.gov/pubmed/35565233
http://dx.doi.org/10.3390/cancers14092102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103968/
https://www.ncbi.nlm.nih.gov/pubmed/35565233
http://dx.doi.org/10.3390/cancers14092102

Ejemplares similares